Carbohydrate-binding module family 9 (CBM9)

Carbohydrate-binding module family 9 (CBM9) consists of non-catalytic protein domains typically found within larger multimodular enzymes, such as xylanases and cellulases, primarily in bacteria. These modules are characterized by their ability to bind specifically to various carbohydrates, including cellulose and xylan, often showing a preference for the reducing ends of these polysaccharides. Biologically, CBM9 domains serve to tether their associated catalytic enzymes to the substrate, thereby enhancing the efficiency of polysaccharide degradation. While CBM9 proteins are not conventional therapeutic targets for human diseases, they are of significant interest in biotechnology for biomass conversion and as molecular tools for carbohydrate detection. In a medical context, they may be studied in the framework of bacterial pathogenesis or utilized in specialized drug delivery systems to target specific glycan structures, though no clinical drugs currently target this family.

Other names

CBM family 9Carbohydrate-binding domain family 9Type C carbohydrate-binding module family 9

CBM9 domains function by increasing the effective concentration of associated catalytic domains (such as xylanases or cellulases) on the surface of complex polysaccharide substrates through high-affinity binding to specific carbohydrate motifs, such as the reducing ends of cellulose or xylan chains.